173 related articles for article (PubMed ID: 15722396)
1. Antistaphylococcal activity of the novel cephalosporin CB-181963 (CAB-175).
Miller K; Storey C; Stubbings WJ; Hoyle AM; Hobbs JK; Chopra I
J Antimicrob Chemother; 2005 Apr; 55(4):579-82. PubMed ID: 15722396
[TBL] [Abstract][Full Text] [Related]
2. Binding of ceftaroline to penicillin-binding proteins of Staphylococcus aureus and Streptococcus pneumoniae.
Moisan H; Pruneau M; Malouin F
J Antimicrob Chemother; 2010 Apr; 65(4):713-6. PubMed ID: 20097788
[TBL] [Abstract][Full Text] [Related]
3. Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus.
Fasola EL; Fasching CE; Peterson LR
J Lab Clin Med; 1995 Feb; 125(2):200-11. PubMed ID: 7844469
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of a novel cephalosporin, CB-181963 (CAB-175), against methicillin-susceptible or -resistant Staphylococcus aureus and glycopeptide-intermediate susceptible staphylococci.
Huang V; Brown WJ; Rybak MJ
Antimicrob Agents Chemother; 2004 Jul; 48(7):2719-23. PubMed ID: 15215134
[TBL] [Abstract][Full Text] [Related]
5. A computational model of antibiotic-resistance mechanisms in methicillin-resistant Staphylococcus aureus (MRSA).
Murphy JT; Walshe R; Devocelle M
J Theor Biol; 2008 Sep; 254(2):284-93. PubMed ID: 18577389
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
7. Beta-lactams against methicillin-resistant Staphylococcus aureus.
Guignard B; Entenza JM; Moreillon P
Curr Opin Pharmacol; 2005 Oct; 5(5):479-89. PubMed ID: 16095969
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of beta-lactam-resistance in methicillin-resistant Staphylococcus aureus].
Okonogi K
Rinsho Byori; 1990 Sep; 38(9):983-9. PubMed ID: 2232271
[TBL] [Abstract][Full Text] [Related]
9. Activation for catalysis of penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus by bacterial cell wall.
Fuda C; Hesek D; Lee M; Morio K; Nowak T; Mobashery S
J Am Chem Soc; 2005 Feb; 127(7):2056-7. PubMed ID: 15713078
[TBL] [Abstract][Full Text] [Related]
10. New and emerging treatment of Staphylococcus aureus infections in the hospital setting.
Moreillon P
Clin Microbiol Infect; 2008 Apr; 14 Suppl 3():32-41. PubMed ID: 18318877
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo activities of echinomycin against clinical isolates of Staphylococcus aureus.
Park YS; Shin WS; Kim SK
J Antimicrob Chemother; 2008 Jan; 61(1):163-8. PubMed ID: 17967852
[TBL] [Abstract][Full Text] [Related]
12. Evolution and resistance expression of MRSA. Evaluation of beta-lactam antibiotics against a set of isogenic strains with different types of phenotypic expression.
Asada K; Inaba Y; Tateda-Suzuki E; Kuwahara-Arai K; Ito T; Hiramatsu K
Acta Biochim Pol; 1995; 42(4):517-24. PubMed ID: 8852342
[TBL] [Abstract][Full Text] [Related]
13. LB11058, a new cephalosporin with high penicillin-binding protein 2a affinity and activity in experimental endocarditis due to homogeneously methicillin-resistant Staphylococcus aureus.
Vouillamoz J; Entenza JM; Hohl P; Moreillon P
Antimicrob Agents Chemother; 2004 Nov; 48(11):4322-7. PubMed ID: 15504859
[TBL] [Abstract][Full Text] [Related]
14. Salvipisone and aethiopinone from Salvia sclarea hairy roots modulate staphylococcal antibiotic resistance and express anti-biofilm activity.
Walencka E; Rozalska S; Wysokinska H; Rozalski M; Kuzma L; Rozalska B
Planta Med; 2007 Jun; 73(6):545-51. PubMed ID: 17650545
[TBL] [Abstract][Full Text] [Related]
15. RWJ-54428 (MC-02,479), a new cephalosporin with high affinity for penicillin-binding proteins, including PBP 2a, and stability to staphylococcal beta-lactamases.
Malouin F; Blais J; Chamberland S; Hoang M; Park C; Chan C; Mathias K; Hakem S; Dupree K; Liu E; Nguyen T; Dudley MN
Antimicrob Agents Chemother; 2003 Feb; 47(2):658-64. PubMed ID: 12543674
[TBL] [Abstract][Full Text] [Related]
16. Risk factors associated with methicillin-resistant Staphylococcus aureus infection in patients admitted to the ED.
Viallon A; Marjollet O; Berthelot P; Carricajo A; Guyomarc'h S; Robert F; Zeni F; Bertrand JC
Am J Emerg Med; 2007 Oct; 25(8):880-6. PubMed ID: 17920971
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
Barcia-Macay M; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
J Antimicrob Chemother; 2006 Dec; 58(6):1177-84. PubMed ID: 17062609
[TBL] [Abstract][Full Text] [Related]
18. Cefmetazole: a broad spectrum cephem antibiotic effective on methicillin- and cephem-resistant Staphylococcus aureus.
Yokota T; Yoshida R; Utsui Y; Tajima M
Drugs Exp Clin Res; 1985; 11(1):29-38. PubMed ID: 3915273
[TBL] [Abstract][Full Text] [Related]
19. Effect of certain bioactive plant extracts on clinical isolates of beta-lactamase producing methicillin resistant Staphylococcus aureus.
Aqil F; Khan MS; Owais M; Ahmad I
J Basic Microbiol; 2005; 45(2):106-14. PubMed ID: 15812867
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for the beta lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus.
Lim D; Strynadka NC
Nat Struct Biol; 2002 Nov; 9(11):870-6. PubMed ID: 12389036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
